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Abstract
Agouti-related protein (AGRP) is a naturally occurring antagonist of melanocortin action. It is expressed mainly in the
arcuate nucleus where it plays an important role in the hypothalamic control of feeding and energy homeostasis by
antagonism of central melanocortin 4 receptors in mammals. Besides in the brain, the melanocortin 4 receptor is expressed in
numerous peripheral tissues in the chicken. To examine whether or not the peripheral melanocortin 4 receptor signaling
could be regulated by AGRP, we cloned and localized the expression of the AGRP gene in the chicken. The chicken AGRP
gene was found to encode a 154 or 165 amino acid protein, depending on the usage of two alternative translation initiation
sites. The coding sequence consisted of three exons, like that of mammalian species. The C-terminal cysteine-rich region of
the predicted AGRP displayed high levels of identity to mammalian counterparts (78^84%) and all 10 cysteine residues
conferring functional conformation of AGRP were conserved; however, other regions showed apparently no homology,
suggesting that biological activities of AGRP are located in its C-terminal region. RT-PCR analysis detected the AGRP
mRNA in all tissues examined: the brain, adrenal gland, heart, liver, spleen, gonads, kidney, uropygial gland, skeletal muscle
and adipose tissues. Interestingly, the skin also expressed the AGRP mRNA, where Agouti, another melanocortin receptor
antagonist regulating hair pigmentation, is expressed in rodents. Most of those AGRP-expressing tissues have been
demonstrated to express melanocortin 4 receptors and/or other subtypes of melanocortin receptor whose mammalian
counterparts can bind AGRP. These results imply the possibility that some peripheral melanocortin systems could be
regulated by the functional interaction between melanocortins and AGRP at melanocortin receptors in the chicken. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
Melanocortin peptides are generated from a com-
mon precursor glycoprotein, pro-opiomelanocortin
(POMC), by post-translational processing [1]. These
peptides include adrenocorticotropic hormone
(ACTH) and melanocyte-stimulating hormones (K-,
L-, and Q-MSH). The POMC gene is expressed
mainly in the anterior and intermediate lobes of the
pituitary and in the arcuate nucleus of the hypothal-
amus, and at a lower level also in a wide variety of
peripheral tissues and brain regions in mammals [2].
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Mammalian melanocortins are now widely recog-
nized to have a broad array of physiological actions
both in the central nervous system and in the periph-
ery, coincident with their wide distribution of expres-
sion and those of their corresponding receptors [2,3].
Five subtypes of melanocortin receptors (MC-Rs)
have been identi¢ed so far with their discrete phar-
macological properties and tissue distributions [3].
Two endogenous antagonists of MC-Rs have re-
cently been identi¢ed, Agouti [4^7] and Agouti-re-
lated protein (AGRP) [8,9], acting in a paracrine
manner to regulate MC-R function. Thus, great
progress has been made over the years in the under-
standing of the molecular mechanisms of melano-
cortin actions in mammals; however, biological
activities of melanocortins are poorly understood in
birds. The physiological signi¢cance of avian K-MSH
remains uncertain as its pituitary gland does not pos-
sess a distinct intermediate lobe of the pituitary, the
main source of circulating K-MSH in most verte-
brates.
Recently, we have isolated all ¢ve receptor genes
belonging to the MC-R family in birds, CMC1
[10,11], CMC2 [12], CMC3 [13], CMC4 and CMC5
[14], which are chicken homologues of mammalian
MC1 (MSH)-R, MC2 (ACTH)-R, MC3-R, MC4-R
and MC5-R, respectively. CMC1 is probably ex-
pressed in melanocytes to regulate melanogenesis,
since it has been mapped at the genetic locus which
acts in a cell autonomous manner within melanocytes
to control feather color pigmentation in the chicken
[11]. CMC2 has been suggested to regulate steroido-
genesis in the adrenal gland and immune functions in
the spleen based on its distribution of expression [12].
Although no function has yet been ascribed to the
other subtypes of MC-R in any tissues of the chick-
en, CMC5 shows as wide a distribution of expression
as in mammals [14], while homologues of the mam-
malian central MC-Rs, CMC3 and CMC4, display
di¡erent tissue distributions from mammals; CMC3
is expressed exclusively in the adrenal gland [13] and
CMC4 in a wide variety of peripheral tissues as well
as in the brain [14]. Since most of those MC-R-ex-
pressing tissues have been found to express the
POMC gene [15], we have hypothesized that avian
melanocortins serve as local mediators acting in a
paracrine and/or autocrine manner to a¡ect a variety
of functions in both the brain and peripheral tissues.
If the hypothesis is true, then inhibitory or feedback
mechanisms should exist for regulating those central
and peripheral melanocortin systems in the chicken.
AGRP has recently been identi¢ed as an endoge-
nous antagonist of melanocortin action [8,9]. It is
mainly expressed in the arcuate nucleus where it
plays an important role in the hypothalamic control
of feeding and energy homeostasis by antagonizing
the central MC4-R signaling in mammals [8,9,16^21].
Pharmacological analyses in vitro have revealed that
the antagonist also binds to both MC3-R [8,9,22^24]
and MC5-R [25] and antagonizes their signalings.
The human and rodent AGRP have been demon-
strated to be expressed also in some peripheral tis-
sues such as the adrenal gland, testis, lung and kid-
ney [8,9]. The chicken MC4-R, CMC4, is quite
similar in primary structure to mammalian counter-
parts, and is expressed in a wide variety of peripheral
tissues in addition to the brain [14]. Furthermore,
some of CMC3, CMC4 and CMC5 have been shown
to be expressed in the tissues where AGRP is ex-
pressed in humans and rodents [13,14]. These pre-
vious ¢ndings led us to speculate that AGRP may
be a local mediator involved in the inhibition of
some melanocortin actions by antagonizing periph-
eral MC-R signalings in the chicken.
To examine the possibility that AGRP could reg-
ulate physiological signalings via MC-Rs expressed
in peripheral tissues, and ultimately for elucidation
and further understanding of how the melanocortin
systems are regulated in birds, it is necessary to char-
acterize the tissue distribution of expression of the
AGRP gene in the chicken. Accordingly, the present
study was designed to isolate the chicken AGRP
gene. In addition, the tissue distribution of AGRP
expression was investigated by reverse transcription
polymerase chain reaction (RT-PCR) analysis.
We describe here for the ¢rst time the cloning and
tissue distribution of expression of an avian AGRP
gene.
2. Materials and methods
2.1. Preparation of probe
DNA fragments encoding a part of the mouse
AGRP gene were obtained by PCR using genomic
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DNA of ICR mice as a template. The primers,
designed from the reported mouse AGRP sequence
(accession number U89484), were TAGATCCACA-
GAACCGCGAGTC and TTCTCATCCCCTGCC-
TTTCCCA. The PCR was carried out using an Am-
pliTaq Gold DNA polymerase (Perkin Elmer, USA)
and a thermal cycler (Gene Amp PCR System 9600,
Perkin Elmer). The conditions for the PCR were as
follows: after activation of the DNA polymerase by
incubating for 9 min at 95‡C, 42 cycles of reactions
including denaturation for 30 s at 95‡C and exten-
sion for 1 min at 60‡C were performed, followed
by additional extension for 10 min at 60‡C. The
ampli¢ed DNA fragments were subcloned into
pGEM3Zf(+) (Promega, USA) and sequenced. Di-
deoxynucleotide sequencing was performed using
£uorescent primers and an automated DNA se-
quencer (Applied Biosystems 373A). The PCR-de-
rived clone, designated pcrmAGRP, was 215 bp in
length and contained a part of the coding sequence
identical to that of the reported mouse AGRP gene.
This clone was used as a probe in this experiment.
2.2. Isolation of the chicken AGRP gene
The pcrmAGRP was radiolabeled using a Random
Primer DNA labeling Kit ver. 2 (Takara, Japan) and
[K-32P]dCTP (Amersham, UK) and used as a probe
to screen a White Leghorn genomic DNA library
(6.02U105 independent clones) cloned into V-FIX
II (Stratagene, USA). Plaques were transferred onto
nylon membrane Hybond N (Amersham, UK), and
were hybridized at 60‡C for 20 h in a solution con-
taining 6USSC, 5UDenhardt’s solution, 0.1% SDS,
and denatured herring sperm DNA (100 Wg/ml).
After a ¢nal wash at 60‡C for 30 min in 2USSC
and 0.1% SDS, the membranes were exposed to
RX-U X-ray ¢lm (Fuji Photo Film, Japan) overnight
at 380‡C with double intensifying screens. Twenty-
four positive clones were isolated out of V1.0U106
phages. Restriction mapping and Southern blotting
revealed that those positive clones overlapped one
another, and were derived from the same gene. The
insert of a positive clone was isolated, further di-
gested with restriction enzymes, subcloned into
pGEM3Zf(+) and subjected to sequencing. Sequence
analysis was carried out using GENETYX software.
This sequence is available from DDBJ, EMBL, and
GenBank data libraries under accession number
AB029443.
2.3. RT-PCR analysis
Total RNA was prepared from the skin of 1-day-
old Rock Cornish chicks and from various tissues of
adult White Leghorn chickens, using the guanidi-
nium thiocyanate/cesium chloride method [26]. 2 Wg
of each total RNA was reverse transcribed using a
SuperScript II reverse transcriptase (Gibco-BRL,
USA) according to the manufacturer’s directions.
One tenth aliquot of reactions was used in each
PCR using speci¢c primers for AGRP, POMC,
MC-Rs (CMC2^CMC5) or glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH). The primers for
AGRP were ATGCTGGCCGGTTGTGCACGTT
(primer I), ATGCTGAACGTGCTGCTGCTGTG
(primer II) and GCAGTAGCAGAAGGCGTT-
GAAGA (primer III). The sequence of speci¢c prim-
ers for POMC, MC-Rs or GAPDH have been de-
scribed elsewhere (for POMC [15]; for CMC2 [12];
for CMC3 [13]; for CMC4, CMC5 and GAPDH
[14]). The PCRs were carried out as described above
for POMC, MC-Rs and GAPDH. For AGRP, the
incubation temperature for extension and annealing
was altered to 66‡C. One tenth aliquot of each reac-
tion was electrophoresed on a 2.0% agarose gel,
stained with ethidium bromide, and photographed
under ultraviolet illumination. In the case of
AGRP, the gel was subsequently transferred onto a
Hybond N and subjected to Southern blot analysis
using the pcrmAGRP as a probe.
Primer pair II and III should produce 1521 and
426 bp products from genomic and complementary
DNA of the chicken AGRP, respectively. Similarly,
primer pair I and III should produce 1554 and 459
bp products, respectively. Ampli¢cation of the
POMC cDNA produces a 426 bp product, whereas
any contaminating genomic DNA yields a 1239 bp
fragment. Each primer set for CMC2, CMC3, CMC4
or CMC5 produces PCR products with the same
size, when cDNA or genomic DNA is the template.
To rule out the possibility that PCR products re-
sulted from the ampli¢cation of genomic DNA con-
taminated in the RNA samples, 1 Wg of the total
RNA was also subjected to PCR using primers for
those MC-Rs. The size of amplicon is 567, 435, 649
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and 448 bp for CMC2, CMC3, CMC4 and CMC5,
respectively.
3. Results and discussion
Genomic clones for AGRP were obtained from a
DNA library of the White Leghorn chicken using the
pcrmAGRP, a part of the third coding exon of the
mouse AGRP gene generated by PCR, as a screening
probe. These clones overlapped one another, and
were classi¢ed into four groups based on the di¡er-
ence in restriction patterns. Clones in one of those
groups contained aV2.7 kb EcoRI fragment hybrid-
Fig. 1. Nucleotide sequence of the chicken AGRP gene. The A of the presumed translation initiation site is denoted +1. The cleavage
site for the signal sequence indicated by a solid arrowhead is predicted by hydropathy analysis [33]. Introns are indicated by lower-
case letters. The putative polyadenylation signal, AATAAA, is marked by asterisks. The location of primers used in this study is de-
noted by underlines and Roman numerals.
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ized with the pcrmAGRP, which was detected in
genomic Southern blotting as a single band with
very weak signal (data not shown). Sequence analysis
of the EcoRI fragment revealed it to contain regions
corresponding to the third coding exon and 3P down-
stream of mammalian AGRP genes. These results
suggest that the chicken genome contains the
AGRP gene as a single copy gene.
Fig. 1 shows the nucleotide sequence of the chick-
en AGRP gene. The sequence homology with mam-
malian AGRP genes and the hydropathy pro¢le of
the deduced amino acid sequence enabled us to esti-
mate the translation initiation site for AGRP within
the chicken genomic sequence (the A of this ATG is
de¢ned as +1 throughout this report), and to design
primers for PCR. By RT-PCR using those primers
(primers II and III), we obtained AGRP cDNAs
from both the brain and adrenal gland of the White
Leghorn chicken. Sequence analysis of those two
cDNAs revealed that they were identical, and pro-
vided us information on the exon-intron boundaries
of the chicken AGRP gene. The chicken AGRP was
found to be encoded by three exons. Two introns
started with GT and ended with AG, in agreement
with the GT/AG rule for exon^intron boundaries. A
typical poly(A) signal was recognized 56 bp down-
stream of the translation stop codon TGA.
The sequence surrounding the presumed transla-
tion initiation site, ACCATGC, was in good agree-
ment with the Kozak consensus sequence for trans-
lation initiation sites [27] ; however, another in-frame
ATG codon was recognized at position 333 to 331.
The mouse genomic sequence (accession number
U89486) also contains an in-frame ATG codon at
position 327 to 325. In humans, it has been re-
ported that the brain expresses V0.7 kb AGRP
mRNA, and peripheral tissues such as the adrenal
gland and lung express that of V0.5 kb in size. 5P
Rapid ampli¢cation of cDNA ends (RACE) analysis
has demonstrated that the larger AGRP mRNA ex-
pressed in human brains contains a long 5P untrans-
lated sequence derived from a single upstream non-
coding exon, and the smaller transcripts expressed in
the peripheral tissues seem to be attributable to the
absence of the exon, and that the splice acceptor site
for the noncoding exon is at position 33 [9]. Since
the sequence surrounding the splice acceptor site,
GAGCCAGGCCATG, is conserved between the
mouse and human AGRP genes, the region contain-
ing the upstream ATG codon is assumed to be in-
tronic material that would not be present in the pro-
cessed mRNA expressed in the mouse brain [9]. It
remains unclear, however, whether the region is
present in mRNA expressed in peripheral tissues. A
similar sequence, GCCCCAGGACCATG, was ob-
served in the chicken AGRP gene at the correspond-
ing position.
To determine whether or not the upstream in-
frame ATG codon is present in the AGRP mRNA
of the brain or adrenal gland in the chicken, we
performed RT-PCR analysis using the region-speci¢c
primer, primer I. Contrary to our expectation, the
region containing the ATG codon was not removed
by splicing, but was present in mature mRNA both
from the brain and from the adrenal gland (Fig. 2).
According to Kozak’s rule [27], the upstream in-
frame ATG codon does not lie in a favorable context
for initiating translation. Although it is unclear at
Fig. 2. Analysis of the chicken AGRP mRNA structure by RT-
PCR. An electrophoretic pattern of each PCR reaction using
primer pairs II and III, or I and III is shown. In each case,
cDNA from the brain or adrenal gland of adult chicken or ge-
nomic DNA was used as a template. A 100 bp ladder used as
a molecular marker is indicated on the left.
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present which of those two ATG codons acts as
translation initiators in vivo or whether they both
do, the chicken AGRP mRNA might have the ability
to direct the synthesis of two separately initiated
AGRPs, each of which contains 165 or 154 amino
acids, respectively. In both cases, the cleavage site for
removal of the signal sequence was predicted to be
identical. Therefore, no di¡erence in biological activ-
ity could be expected between those two AGRPs.
Comparison of the structural organization of the
chicken AGRP gene with that of known mammalian
AGRP genes is schematically presented in Fig. 3.
Except for the upstream noncoding exon which has
been identi¢ed so far only in humans, the chicken
AGRP gene showed largely the same structural orga-
nization as that of the human and mouse AGRP
genes; the predicted AGRP molecule was encoded
by three exons, and a typical poly(A) signal was lo-
cated within the region 100 bp downstream of the
translation stop codon TGA. All coding exons and
an intron between the second and third coding exons
of the chicken AGRP gene were large in size in com-
parison to those of the mouse and human AGRP
genes. Especially the intron between the second and
third coding exons was 981 bp in length, where those
Fig. 3. Schematic representation of the gene structure of AGRP
of the chicken and mammalian species. Exons are denoted by
boxes and coding regions for AGRP are indicated by shading.
Fig. 4. Alignment of the predicted amino acid sequence of the chicken AGRP with that of di¡erent species. The chicken AGRP se-
quence is compared to the human, bovine and mouse AGRP. Identities with the chicken AGRP are indicated by dots. Missing resi-
dues are shown by bars. The solid arrowheads indicate the conserved cysteine residues. The C-terminal domain with biological activ-
ities of AGRP [25,29^31] is underlined, and the region critical in determining the antagonist activity of the human AGRP [24] is
indicated by a solid box.
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of the mouse and human genes are 181 and 206 bp,
respectively [9]. No known sequence could be found
by a homology search on an EMBL DNA database
in the intron of the chicken AGRP gene.
The alignment of the predicted amino acid se-
quence of the chicken AGRP with that of the mouse,
bovine (accession number AJ002025) and human
AGRP genes is shown in Fig. 4. Overall, the chicken
AGRP was 45, 47 and 45% identical at the amino
acid level to the mouse, bovine and human AGRP,
respectively. A high degree of sequence conservation
was observed in the C-terminal domain where all
10 cysteine residues, conserved among all known
AGRP and forming ¢ve disul¢de bonds [28], were
recognized in the chicken AGRP, whereas other re-
gions showed weak or no homology. Recent pharma-
cological and biochemical studies have demonstrated
that the C-terminal domain of the human AGRP
(83^132 or 87^132) is functionally equivalent to the
intact human AGRP [25,29^31], and that the loop
de¢ned by Cys-110 and Cys-117 is critical in deter-
mining the antagonist activity of the human AGRP
[24]. The chicken AGRP (106^154), which corre-
sponds to the human AGRP (83^132), displayed
78, 84 and 78% identity to the mouse, bovine and
human AGRP, respectively, and the region corre-
sponding to the human AGRP (110^117) was con-
served in the chicken AGRP. These observations not
only support the previous reports showing that the
C-terminal cysteine-rich region is su⁄cient for bio-
logical activity of AGRP, but also suggest that the
chicken AGRP has similar biological activities to
mammalian AGRP. As in the case of mammalian
AGRP, sequence similarity of the chicken AGRP
to Agouti [4] was limited to a short region within
the C-terminal domain, and the region of basic ami-
no acids in the middle of Agouti was not observed in
the chicken AGRP, nor was the series of polyproline
residues.
The expression pattern of the chicken AGRP was
determined by RT-PCR analysis of RNA from a
variety of tissues of adult White Leghorn chickens.
The chicken AGRP gene was found to be expressed
in all tissues examined, including the heart, kidney,
liver, spleen, gonads, uropygial gland, skeletal muscle
and adipose tissue, besides the brain and adrenal
gland (Fig. 5A). In addition, the RT-PCR analysis
using the primer pair I and III revealed that the
mature AGRP mRNA expressed in all of those tis-
sues contained the upstream alternative translation
initiation site (Fig. 5B). Shutter et al. [9] have local-
ized the expression of AGRP in the brain, adrenal
gland, lung and testis in humans and mice by North-
ern blot analysis and RT-PCR analysis followed by
ethidium bromide staining, respectively. Ollmann et
al. [8], on the other hand, have detected the mouse
AGRP expression in the brain, adrenal gland, kid-
ney, lung, ovary and muscle by Southern blotting of
RT-PCR products. Both reports have clearly demon-
strated that the AGRP gene is expressed with tissue
speci¢city and its expression level varies with tissue
Fig. 5. RT-PCR analysis of AGRP mRNA expression in vari-
ous tissues of adult White Leghorn chickens. (A) An electro-
phoretic pattern and a Southern blot of each PCR reaction us-
ing primer pair II and III, and cDNA from various tissues as a
template are shown. (B) An electrophoretic pattern and a
Southern blot of each PCR reaction using primer pair I and
III, and cDNA from various tissues as a template are shown.
In each case, a 100 bp ladder used as a molecular marker is in-
dicated on the left.
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type. In contrast, the chicken AGRP gene was evenly
expressed in all tissues examined when assessed by
RT-PCR, although the RT-PCR technique is essen-
tially qualitative. Except for the heart, liver and ur-
opygial gland, all AGRP-expressing tissues identi¢ed
here have been demonstrated to express CMC4 in
the chicken [14]. Both the liver and uropygial gland
have been shown to express CMC5 [14] whose mam-
malian counterparts can bind AGRP [25]. Although
the expression of AGRP in the heart does not appear
to colocalize with any known MC-Rs, it seems pos-
sible that AGRP could be providing inhibitory reg-
ulation of melanocortin actions in those peripheral
tissues, analogous to the hypothalamic control of
feeding by AGRP in mammals.
We have attempted as well to clone the chicken
Agouti, another endogenous antagonist of MC-Rs,
using the entire third coding exon of the mouse
Agouti gene generated by PCR as a screening probe.
The third coding exon of mammalian Agouti genes
encodes characteristic sequences of Agouti protein,
including the C-terminal cysteine-rich region, the re-
gion of basic amino acids in the middle of Agouti
and the series of polyproline residues. Although the
mouse Agouti probe detected a large number of pos-
itive clones from the chicken genomic DNA library
at medium stringent conditions (¢nal wash was per-
formed with 1USSC/0.1% SDS at 65‡C), sequence
analysis of those positive clones revealed that they
did not encode the chicken homologue or related
proteins of mammalian Agouti, but contained repet-
itive sequences with high levels of G/C content, sug-
gesting that the sequence similarity between the
chicken and the mouse Agouti sequences is limited,
or that the chicken genome does not contain the
Agouti gene (S. Takeuchi, personal communication).
In mice, Agouti is expressed in the skin where it
plays an important role in the regulation of coat
pigmentation by antagonizing MC1-R signaling on
melanocytes [4,5]. Since mammalian AGRP is a po-
tent antagonist of the MC-R expressed in Xenopus
melanophores [8], it would be possible that the chick-
en AGRP functions as a physiological antagonist of
CMC1 on melanocytes in place of Agouti. To parti-
ally address this question, we investigated the AGRP
expression in the skin of 1-day-old Rock Cornish
chicks. Surprisingly, the chicken skin did express
the AGRP gene as well as that for POMC (Fig. 6).
The skin also expressed CMC5, which might be con-
sidered to be expressed in sebaceous glands to regu-
late lipid secretion by analogy with mammalian
MC5-Rs [32]. It is unclear at present whether
MC1-R signaling in the chicken melanocytes is co-
regulated by melanocortins and AGRP expressed in
the skin; however, it is possible that AGRP is the
sole endogenous MC-R antagonist in the chicken,
and mammalian Agouti is of relatively recent evolu-
tionary origin.
The present study detected AGRP gene expression
in all tissues examined. Although detailed cellular
localization of its expression is required, it is prob-
able that AGRP gene expression is cell type-speci¢c
and con¢ned to quite limited regions in those tissues,
because Northern analysis of total RNA from those
tissues failed to detect AGRP mRNA (data not
shown). It remains possible, however, that the
AGRP gene is expressed ubiquitously at a level be-
low the sensitivity of our Northern blotting. If the
AGRP gene were expressed ubiquitously in the
chicken, physiological characteristics of chickens
such as physiological hyperinsulinemia and hypergly-
cemia (2 g/l) might re£ect the unique expression pat-
tern of the AGRP gene, for ubiquitous expression of
the human AGRP cDNA in transgenic mice results
in an obesity syndrome associated with hyperinsuli-
nemia and hyperglycemia [8]. Alternatively, the
AGRP expression pattern observed in White Leg-
horn chickens might result from an unusual mutation
analogous to the Ay Agouti allele in mice [4], and the
Fig. 6. RT-PCR analysis of the expression of POMC, AGRP
and MC-Rs mRNAs in the skin of 1-day-old chicks (Rock Cor-
nish). An electrophoretic pattern of PCR reaction using each
speci¢c primers is shown. A 100 bp ladder used as a molecular
marker is indicated on the left. Negative controls are indicated
by RT(3).
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expression pattern might vary among di¡erent chick-
en breeds. Further analyses are required to verify
these possibilities.
In conclusion, the present study determined the
primary structure of the chicken AGRP by deducing
from its genomic and complementary DNA sequen-
ces, and demonstrated that the chicken AGRP is ex-
pressed in the brain and in a wide variety of periph-
eral tissues. Whether AGRP is e¡ectively secreted
and endowed with physiological functions in
AGRP-expressing tissues identi¢ed here awaits fur-
ther analysis; however, the present results provide
the possibility that AGRP could be involved by
paracrine and/or autocrine mechanisms in the regu-
lation of MC-R signalings in a wide variety of pe-
ripheral tissues in the chicken. Pharmacological anal-
ysis of the speci¢city of the chicken AGRP for MC-
Rs should help elucidate the molecular mechanisms
by which peripheral melanocortin systems are regu-
lated in birds.
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